Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04283097
Title Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kangpu Biopharmaceuticals, Ltd.
Indications

multiple myeloma

chronic lymphocytic leukemia

adult T-cell leukemia/lymphoma

mantle cell lymphoma

lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

KPG-818

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.